Med Fusion LungSEQ and 50SEQ Plus FISH Laboratory Service Expansion

GenomOncology and med fusion announced the expansion of med fusion's LungSEQ and 50SEQ Plus FISH laboratory services to include PD-L1 expression testing. The original services provided a variety of testing services for patients with non-small cell lung cancer. The panels expansion to test results or the status of PD-L1 will determine if patients may be eligible for new-FDA immunotherapies, the companies said.